Back to search

Article

Untargeted <sup>1</sup> H NMR-based metabolomics reveal sex-based differences in blood metabolome profiles among patients with Parkinson’s disease, regardless of their idiopathic or genetic subtype

2025-11-02

Abstract excerpt

Emerging findings indicate systemic metabolic dysregulations linked to Parkinson’s disease (PD) pathophysiology. However, the specific effects of sex and subtype differences on blood metabolomic abnormalities in patients compared with controls remain elusive. Here, we conducted an untargeted 1 H NMR-based analysis to characterize serum metabolome variations in a large cohort of clinically and genetically characte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
782c56e6-30e7-52b5-b86c-a25e8ec7231d
DOI
10.1101/2025.10.30.25339159
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Untargeted <sup>1</sup> H NMR-based metabolomics reveal sex-based differences in blood metabolome profiles among patients with Parkinson’s disease, regardless of their idiopathic or genetic subtypeDOI 10.1101/2025.10.30.25339159
Discovery of Sexual Dimorphism in the Serum Metabolome of Parkinson’s Disease Patients Harboring Rare Genetic Variants with Uncertain PathogenicitySemantic proximity
Sex differences impact serum metabolome profiles in patients with familial Parkinson’s diseaseSemantic proximity
Mutations in the <i>GBA1</i> , <i>LRRK2</i> , <i>TMEM175</i> , <i>PARK2</i> , <i>PINK1</i> , and <i>PARK7</i> genes lead to sex-specific serum metabolic changes in patients with Parkinson’s diseaseSemantic proximity
Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersSemantic proximity
Metabolomics of blood reveals age-dependent pathways in Parkinson’s DiseaseSemantic proximity
Metabolomic Changes in Idiopathic and <i>GBA1</i> Parkinson’s DiseaseSemantic proximity
Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.Semantic proximity
Sex and genotype influence the disruption of circulating NMDAR-related amino acids in patients with Parkinson’s diseaseSemantic proximity
The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and<i>PRKN/PINK1</i>-mediated Parkinson’s disease – a large-scale targeted metabolomics studySemantic proximity
Levodopa and dopamine dynamics in Parkinson’s disease metabolomicsSemantic proximity
Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot studySemantic proximity
Select a neighboring publication to make it the new centre.